TipRanks
Crispr Therapeutics AG (DE:1CG)
FRANKFURT:1CG
Germany Market
1CG
Crispr Therapeutics AG
RESEARCH TOOLSreports

Crispr Therapeutics AG (1CG) Cash flow

22 Followers

Crispr Therapeutics AG Cash Flow

DE:1CG's free cash flow for Q2 2026 was $-86.62M. For the 2026 fiscal year, DE:1CG's free cash flow was decreased by $-201.25M and operating cash flow was $-83.50M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -345.01M$ -142.77M$ -260.38M$ -495.74M$ 538.97M
Investing Cash Flow
$ -31.80M$ -280.48M$ 374.65M$ -258.65M$ -1.04B
Financing Cash Flow
$ 426.03M$ 331.98M$ 62.66M$ 38.59M$ 250.94M
End Cash Position
$ 359.08M$ 309.78M$ 389.48M$ 224.06M$ 939.94M
Free Cash Flow
$ -345.93M$ -144.68M$ -269.85M$ -532.93M$ 457.27M
Currency in USD

Crispr Therapeutics AG Cash Flow